Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

In vivo and in vitro methods for evaluating soil arsenic bioavailability: relevant to human health risk assessment.

Bradham KD, Diamond GL, Burgess M, Juhasz A, Klotzbach JM, Maddaloni M, Nelson C, Scheckel K, Serda SM, Stifelman M, Thomas DJ.

J Toxicol Environ Health B Crit Rev. 2018;21(2):83-114. doi: 10.1080/10937404.2018.1440902.

PMID:
29553912
2.

A physiologically based pharmacokinetic model for the broad-spectrum antimicrobial zinc pyrithione: I. Development and verification.

Diamond GL, Skoulis NP, Jeffcoat AR, Nash JF.

J Toxicol Environ Health A. 2017;80(2):69-90. doi: 10.1080/15287394.2016.1245123. Epub 2017 Jan 13.

PMID:
28085645
3.

Estimating relative bioavailability of soil lead in the mouse.

Bradham KD, Green W, Hayes H, Nelson C, Alava P, Misenheimer J, Diamond GL, Thayer WC, Thomas DJ.

J Toxicol Environ Health A. 2016;79(24):1179-1182. Epub 2016 Oct 21.

PMID:
27767405
4.

Predicting oral relative bioavailability of arsenic in soil from in vitro bioaccessibility.

Diamond GL, Bradham KD, Brattin WJ, Burgess M, Griffin S, Hawkins CA, Juhasz AL, Klotzbach JM, Nelson C, Lowney YW, Scheckel KG, Thomas DJ.

J Toxicol Environ Health A. 2016;79(4):165-73. doi: 10.1080/15287394.2015.1134038.

PMID:
27029599
5.

Amending soils with phosphate as means to mitigate soil lead hazard: a critical review of the state of the science.

Scheckel KG, Diamond GL, Burgess MF, Klotzbach JM, Maddaloni M, Miller BW, Partridge CR, Serda SM.

J Toxicol Environ Health B Crit Rev. 2013;16(6):337-80. doi: 10.1080/10937404.2013.825216. Review.

PMID:
24151967
6.

Toxicological Profile for Radon.

Keith S, Doyle JR, Harper C, Mumtaz M, Tarrago O, Wohlers DW, Diamond GL, Citra M, Barber LE.

Atlanta (GA): Agency for Toxic Substances and Disease Registry (US); 2012 May.

7.

Mouse assay for determination of arsenic bioavailability in contaminated soils.

Bradham KD, Diamond GL, Scheckel KG, Hughes MF, Casteel SW, Miller BW, Klotzbach JM, Thayer WC, Thomas DJ.

J Toxicol Environ Health A. 2013;76(13):815-26. doi: 10.1080/15287394.2013.821395.

PMID:
24028666
8.

Toxicological Profile for RDX.

Abadin H, Smith C, Ingerman L, Llados FT, Barber LE, Plewak D, Diamond GL.

Atlanta (GA): Agency for Toxic Substances and Disease Registry (US); 2012 Jan.

9.

Toxicological Profile for Carbon Monoxide.

Wilbur S, Williams M, Williams R, Scinicariello F, Klotzbach JM, Diamond GL, Citra M.

Atlanta (GA): Agency for Toxic Substances and Disease Registry (US); 2012 Jun.

10.

Toxicological Profile for 1,4-Dioxane.

Wilbur S, Jones D, Risher JF, Crawford J, Tencza B, Llados F, Diamond GL, Citra M, Osier MR, Lockwood LO.

Atlanta (GA): Agency for Toxic Substances and Disease Registry (US); 2012 Apr.

11.

Issues related to time averaging of exposure in modeling risks associated with intermittent exposures to lead.

Lorenzana RM, Troast R, Klotzbach JM, Follansbee MH, Diamond GL.

Risk Anal. 2005 Feb;25(1):169-78.

PMID:
15787766
12.
13.

Application of geostatistics to risk assessment.

Thayer WC, Griffith DA, Goodrum PE, Diamond GL, Hassett JM.

Risk Anal. 2003 Oct;23(5):945-60.

PMID:
12969410
14.

Lead intervention and pediatric blood lead levels at hazardous waste sites.

Lorenzana RM, Troast R, Mastriano M, Follansbee MH, Diamond GL.

J Toxicol Environ Health A. 2003 May 23;66(10):871-93. Review.

PMID:
12825235
16.

Urinary cadmium elimination as a biomarker of exposure for evaluating a cadmium dietary exposure--biokinetics model.

Choudhury H, Harvey T, Thayer WC, Lockwood TF, Stiteler WM, Goodrum PE, Hassett JM, Diamond GL.

J Toxicol Environ Health A. 2001 Jul 6;63(5):321-50.

PMID:
11471865
17.

Hazard identification and dose response of ingested nickel-soluble salts.

Haber LT, Diamond GL, Zhao Q, Erdreich L, Dourson ML.

Regul Toxicol Pharmacol. 2000 Apr;31(2 Pt 1):231-41.

PMID:
10854128
18.

Hazard identification and dose response of inhaled nickel-soluble salts.

Haber LT, Erdreicht L, Diamond GL, Maier AM, Ratney R, Zhao Q, Dourson ML.

Regul Toxicol Pharmacol. 2000 Apr;31(2 Pt 1):210-30. Review.

PMID:
10854127
19.

Gastrointestinal absorption of metals.

Diamond GL, Goodrum PE, Felter SP, Ruoff WL.

Drug Chem Toxicol. 1998 May;21(2):223-51. Review.

PMID:
9598302
20.

Understanding renal toxicity of heavy metals.

Diamond GL, Zalups RK.

Toxicol Pathol. 1998 Jan-Feb;26(1):92-103. Review.

PMID:
9502391
21.

Gastrointestinal absorption of metals.

Diamond GL, Goodrum PE, Felter SP, Ruoff WL.

Drug Chem Toxicol. 1997 Nov;20(4):345-68. Review. Corrected and republished in: Drug Chem Toxicol. 1998 May;21(2):223-51.

PMID:
9433663
22.
23.

Reversible uranyl fluoride nephrotoxicity in the Long Evans rat.

Diamond GL, Morrow PE, Panner BJ, Gelein RM, Baggs RB.

Fundam Appl Toxicol. 1989 Jul;13(1):65-78.

PMID:
2767362
24.

Complexing activity of 2,3-dimercapto-1-propanesulfonate and its disulfide auto-oxidation product in rat kidney.

Diamond GL, Klotzbach JM, Stewart JR.

J Pharmacol Exp Ther. 1988 Jul;246(1):270-4.

PMID:
3392658
25.

Nephrotoxicity of uranyl fluoride in uninephrectomized and sham-operated rats.

Zalups RK, Gelein RM, Morrow PE, Diamond GL.

Toxicol Appl Pharmacol. 1988 Jun 15;94(1):11-22.

PMID:
3376109
26.

Complexing activity and excretion of 2,3-dimercapto-1-propane sulfonate in rat kidney.

Klotzbach JM, Diamond GL.

Am J Physiol. 1988 Jun;254(6 Pt 2):F871-8.

PMID:
3381889
27.

In vivo renal tubular secretion and metabolism of the disulfide of 2,3-dimercaptopropane-1-sulfonate.

Stewart JR, Diamond GL.

Drug Metab Dispos. 1988 Mar-Apr;16(2):189-95.

PMID:
2898331
28.

Enhanced accumulation of injected inorganic mercury in renal outer medulla after unilateral nephrectomy.

Zalups RK, Klotzbach JM, Diamond GL.

Toxicol Appl Pharmacol. 1987 Jun 30;89(2):226-36.

PMID:
3603559
29.

Renal tubular secretion of the alkanesulfonate 2,3-dimercapto-1-propanesulfonate.

Stewart JR, Diamond GL.

Am J Physiol. 1987 May;252(5 Pt 2):F800-10.

PMID:
3034073
30.

Intrarenal distribution of mercury in the rat: effect of administered dose of mercuric chloride.

Zalups RK, Diamond GL.

Bull Environ Contam Toxicol. 1987 Jan;38(1):67-72. No abstract available.

PMID:
3814853
31.

Mercuric chloride-induced nephrotoxicity in the rat following unilateral nephrectomy and compensatory renal growth.

Zalups RK, Diamond GL.

Virchows Arch B Cell Pathol Incl Mol Pathol. 1987;53(6):336-46.

PMID:
2891217
32.

Renal handling of cadmium in perfused rat kidney and effects on renal function and tissue composition.

Diamond GL, Cohen JJ, Weinstein SL.

Am J Physiol. 1986 Nov;251(5 Pt 2):F784-94.

PMID:
3777178
33.

Bioavailability and pharmacological effects of two slow-release theophylline preparations: intrasubject tablet-to-tablet variability.

Rivera-Calimlim L, Calimlim JF, Liang R, Lasagna L, Diamond GL.

J Asthma. 1986;23(3):113-22.

PMID:
3528119
34.

Resistance to cadmium-induced necrosis in testes of inbred mice: possible role of a metallothionein-like cadmium-binding protein.

Chellman GJ, Shaikh ZA, Baggs RB, Diamond GL.

Toxicol Appl Pharmacol. 1985 Jul;79(3):511-23.

PMID:
4035692
35.

Quantitative determination of organ contribution to excretory metabolism.

Tremaine LM, Diamond GL, Quebbemann AJ.

J Pharmacol Methods. 1985 Feb;13(1):9-35.

PMID:
3974258
36.

In vivo quantification of renal glucuronide and sulfate conjugation of 1-naphthol and p-nitrophenol in the rat.

Tremaine LM, Diamond GL, Quebbemann AJ.

Biochem Pharmacol. 1984 Feb 1;33(3):419-27.

PMID:
6704161
37.

Salicylate enhancement of renal glucuronide conjugation and tubular excretory transfer of phenols.

Diamond GL, Anders MW, Tremaine LM, Quebbemann AJ.

Drug Metab Dispos. 1982 Nov-Dec;10(6):573-8.

PMID:
6130902
38.

In vivo quantification of renal sulfate and glucuronide conjugation in the chicken.

Diamond GL, Quebbemann AJ.

Drug Metab Dispos. 1981 Sep-Oct;9(5):402-9.

PMID:
6117437

Supplemental Content

Loading ...
Support Center